Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-26

Clinical Trial Update: Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing bioequivalence of ciprofloxacin/dexamethasone otic suspensions in children with tympanostomy tubes; study terminated with no results rep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension (ciprofloxacin; dexamethasone)

Snippet

Sponsor: Par Pharmaceutical, Inc. | Conditions: Otitis Media in Patients With Tympanostomy Tubes | Phase 3 | Status: TERMINATED